We are live on
!
Find out more
FCM
Frontier Capital Management Portfolio holdings
AUM
$9.73B
1-Year Est. Return
55.65%
This Fund
S&P 500
This Quarter
Est. Return
+6.44%
1 Year Est. Return
+55.65%
3 Year Est. Return
+154.46%
5 Year Est. Return
+213.15%
10 Year Est. Return
+1,202.39%
AUM
$13.3B
AUM Growth
-$803M
(-5.7%)
Cap. Flow
-$1.32B
Cap. Flow
% of AUM
-9.99%
Top 10 Holdings %
Top 10 Hldgs %
14.78%
Holding
321
New
25
Increased
69
Reduced
194
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aon
AON
|
+$100M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$90.6M |
| 3 |
L3Harris
LHX
|
+$80.3M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$74.9M |
| 5 |
Texas Capital Bancshares
TCBI
|
+$61.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$98.9M |
| 2 |
SS&C Technologies
SSNC
|
+$97.6M |
| 3 |
Raymond James Financial
RJF
|
+$93.8M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$83.2M |
| 5 |
Insulet
PODD
|
+$75.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.85% |
| 2 | Industrials | 17.67% |
| 3 | Consumer Discretionary | 14.18% |
| 4 | Healthcare | 13.98% |
| 5 | Financials | 11.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DOCU
251
DocuSign
DOCU
$11.1B
| $6.17M | 0.05% |
124,111
+101,229
| +442% | +$5.41M |
|
252
Golar LNG
GLNG
$4.82B
| $5.75M | 0.04% |
311,262
-128,106
| -29% | -$2.44M |
|
253
Glaukos
GKOS
$9.49B
| $5.56M | 0.04% |
+73,734
| New | +$5.29M |
|
254
Kratos Defense & Security Solutions
KTOS
$8.23B
| $5.43M | 0.04% |
237,282
+149,691
| +171% | +$2.82M |
|
255
Alnylam Pharmaceuticals
ALNY
$38.3B
| $5.42M | 0.04% |
74,689
+6,563
| +10% | +$504K |
|
|
HOME
256
DELISTED
At Home Group Inc.
HOME
| $5.14M | 0.04% |
772,161
+477,610
| +162% | +$8.46M |
|
257
Strategic Education
STRA
$1.98B
| $4.88M | 0.04% |
27,413
+10,913
| +66% | +$1.79M |
|
258
Trade Desk
TTD
$8.97B
| $4.85M | 0.04% |
212,740
+199,680
| +1,529% | +$4.29M |
|
|
GHL
259
DELISTED
Greenhill & Co., Inc.
GHL
| $4.76M | 0.04% |
350,350
-144,210
| -29% | -$2.65M |
|
|
INVX
260
Innovex International
INVX
$1.8B
| $4.76M | 0.04% |
99,177
-40,907
| -29% | -$1.78M |
|
|
COUP
261
DELISTED
Coupa Software Incorporated
COUP
| $4.74M | 0.04% |
37,407
-26,810
| -42% | -$2.88M |
|
|
DPLO
262
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $4.7M | 0.04% |
772,134
-320,046
| -29% | -$1.7M |
|
263
FerroAtlántica
GSM
$590M
| $4.46M | 0.03% |
2,621,222
-1,077,871
| -29% | -$2.05M |
|
264
Zscaler
ZS
$24.9B
| $4.19M | 0.03% |
+54,613
| New | +$3.89M |
|
265
Karyopharm Therapeutics
KPTI
$155M
| $4.09M | 0.03% |
45,524
-34
| -0.1% | -$2.73K |
|
266
Amneal Pharmaceuticals
AMRX
$6.1B
| $4.07M | 0.03% |
567,066
-233,715
| -29% | -$2.39M |
|
|
LTHM
267
DELISTED
Livent Corporation
LTHM
| $3.93M | 0.03% |
567,425
+129,272
| +30% | +$1.16M |
|
|
IIN
268
DELISTED
IntriCon Corporation
IIN
| $3.91M | 0.03% |
167,198
+137,198
| +457% | +$3.43M |
|
269
Natera
NTRA
$36.4B
| $3.88M | 0.03% |
+140,788
| New | +$3.11M |
|
|
HA
270
DELISTED
Hawaiian Holdings, Inc.
HA
| $3.77M | 0.03% |
137,504
-14,672
| -10% | -$398K |
|
|
NE
271
DELISTED
Noble Corporation
NE
| $3.39M | 0.03% |
1,812,134
+20,283
| +1% | +$47.7K |
|
|
GBT
272
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $3.33M | 0.03% |
+63,268
| New | +$3.64M |
|
|
SGMO
273
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $3.17M | 0.02% |
294,448
-120,808
| -29% | -$1.28M |
|
|
FRTA
274
DELISTED
Forterra, Inc
FRTA
| $2.99M | 0.02% |
601,209
-1,868,010
| -76% | -$9.09M |
|
275
Madrigal Pharmaceuticals
MDGL
$12.6B
| $2.88M | 0.02% |
27,475
-60,228
| -69% | -$6.45M |
|
Similar funds
HL
DCP
CCM
URS
CIM
MPI
TIM
DPIM
Frontier Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Frontier Capital Management held 321 positions worth $13.3B, down 5.7% from $14.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Frontier Capital Management withdrew a net $1.32B in Q2 2019, closing 33 positions and reducing 194 holdings. Its most notable exit was PRA Health Sciences, Inc., an estimated $98.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Frontier Capital Management opened a new position in IHS Markit Ltd. Common Shares worth $101M.
- Frontier Capital Management's largest Q2 2019 buy was IHS Markit Ltd. Common Shares: 1,577,841 shares worth $101M.
- Frontier Capital Management added most to Aon in Q2 2019, an estimated $100M increase.
- Frontier Capital Management's biggest Q2 2019 reduction was SS&C Technologies, cutting an estimated $97.6M.
- Frontier Capital Management fully exited PRA Health Sciences, Inc. in Q2 2019, selling an estimated $98.9M.
- Frontier Capital Management's ten largest holdings make up 15% of its $13.3B portfolio in Q2 2019.
- Frontier Capital Management opened 25 new positions and closed 33 in Q2 2019.
- Frontier Capital Management's portfolio value fell 5.7% quarter-over-quarter to $13.3B.
Based on Frontier Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.